BridgeMD
Compares treatment options for Lumbosacral Radiculopathy
Official title US vs FL-Guided Lumbar Nerve Root Injections
ClinicalTrials.gov ID: NCT07627308
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if ultrasound-guided nerve root injections work as well as fluoroscopy (X-ray)-guided injections to treat lower back and leg pain caused by irritated nerves (lumbosacral radiculopathy) in adults aged 18 to 75 years old. The main questions it aims to answer are: Does ultrasound guidance lower pain as effectively as fluoroscopy guidance after 3 months?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Adults aged 18 to 75 years.
- Clinical diagnosis of lumbar radiculopathy characterized by radicular pain, paresthesia, or weakness in a dermatomal distribution.
- Magnetic Resonance Imaging (MRI)-confirmed nerve root compression due to disc herniation or foraminal stenosis.
- Failure to respond to at least 3 months of conservative medical treatment.
- Radiculopathy affecting the L4, L5, or combined L5-S1 levels (where the primary symptomatic level can be reliably targeted)
You likely can't join if
- Isolated S1 radiculopathy.
- Significant spinal deformities, including scoliosis \>20° or spondylolisthesis \>Grade II.
- History of prior lumbar spine surgery.
- Bleeding disorders (International Normalized Ratio [INR] \>2.5).
- Severe uncontrolled diabetes mellitus (HbA1c \>8%).
- Advanced cardiac, renal, or hepatic disease.
See the full eligibility criteria
- Adults aged 18 to 75 years.
- Clinical diagnosis of lumbar radiculopathy characterized by radicular pain, paresthesia, or weakness in a dermatomal distribution.
- Magnetic Resonance Imaging (MRI)-confirmed nerve root compression due to disc herniation or foraminal stenosis.
- Failure to respond to at least 3 months of conservative medical treatment.
- Radiculopathy affecting the L4, L5, or combined L5-S1 levels (where the primary symptomatic level can be reliably targeted)
- Isolated S1 radiculopathy.
- Significant spinal deformities, including scoliosis \>20° or spondylolisthesis \>Grade II.
- History of prior lumbar spine surgery.
- Bleeding disorders (International Normalized Ratio [INR] \>2.5).
- Severe uncontrolled diabetes mellitus (HbA1c \>8%).
- Advanced cardiac, renal, or hepatic disease.
- Active systemic infection or localized infection at the injection site.
- Known allergies to corticosteroids or local anesthetics.
- Presence of progressive neurological deficits or cauda equina syndrome.
- Peripheral neuropathies mimicking radiculopathy.
- Pregnancy or breastfeeding.
- Severe psychiatric illness or cognitive impairment affecting study compliance.
The study team makes the final eligibility decision.
Where it's taking place
- Tanta, Gharbia Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tanta, Gharbia Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.